Transient elastography for monitoring the fibrosis of non‐alcoholic fatty liver disease for 4 years

There have been some reports on the use of paired biopsies for monitoring disease progression in non‐alcoholic fatty liver disease (NAFLD) patients. Recently, transient elastography has been developed as a non‐invasive method for predicting the severity of liver fibrosis. We investigated 4‐year disease progression in NAFLD patients by evaluating liver stiffness measurements (LSM) obtained using transient elastography.

[1]  Vincent Wai-Sun Wong,et al.  Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years , 2010, Gut.

[2]  Z. Sparchez,et al.  Performance of unidimensional transient elastography in staging non-alcoholic steatohepatitis. , 2010, Journal of gastrointestinal and liver diseases : JGLD.

[3]  Julien Vergniol,et al.  Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease , 2010, Hepatology.

[4]  S. Caldwell,et al.  Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. , 2009, Journal of hepatology.

[5]  H. Kirikoshi,et al.  Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[6]  B. Neuschwander‐Tetri,et al.  Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease , 2008, Gut.

[7]  J. Hayashi,et al.  Transient elastography for patients with chronic hepatitis B and C virus infection: Non‐invasive, quantitative assessment of liver fibrosis , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[8]  K. Eguchi,et al.  Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[9]  A. Nakajima,et al.  Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD) , 2007, Gut.

[10]  T. Therneau,et al.  The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD , 2007, Hepatology.

[11]  J. Montaner,et al.  Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection , 2006, Hepatology.

[12]  P. Giral,et al.  Sampling variability of liver biopsy in nonalcoholic fatty liver disease. , 2005, Gastroenterology.

[13]  F. Kinjo,et al.  Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease. , 2005, World journal of gastroenterology.

[14]  M. Ziol,et al.  Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. , 2003, Ultrasound in medicine & biology.

[15]  V. Paradis,et al.  Sampling variability of liver fibrosis in chronic hepatitis C , 2003, Hepatology.

[16]  J. Kalbfleisch,et al.  A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C , 2003, Hepatology.

[17]  G. Farrell.  Non‐alcoholic steatohepatitis: What is it, and why is it important in the Asia–Pacific region? , 2003, Journal of gastroenterology and hepatology.

[18]  J. Dienstag,et al.  The role of liver biopsy in chronic hepatitis C , 2002, Hepatology.

[19]  J. Fruit,et al.  The role of liver biopsy in chronic hepatitis C , 2002 .

[20]  E. Schiff,et al.  Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection , 2002, American Journal of Gastroenterology.

[21]  Cadranel Jf.  [Good clinical practice guidelines for fine needle aspiration biopsy of the liver: past, present and future]. , 2002 .

[22]  M. Fink,et al.  Shear elasticity probe for soft tissues with 1-D transient elastography , 2002, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[23]  P. Bedossa,et al.  Appropriateness of liver biopsy. , 2000, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[24]  P. Giral,et al.  Liver fibrosis in overweight patients. , 2000, Gastroenterology.

[25]  B. Maharaj,et al.  SAMPLING VARIABILITY AND ITS INFLUENCE ON THE DIAGNOSTIC YIELD OF PERCUTANEOUS NEEDLE BIOPSY OF THE LIVER , 1986, The Lancet.

[26]  E. Mezey,et al.  Sampling variability on percutaneous liver biopsy. , 1979, Archives of internal medicine.

[27]  Plumley Pf.  Letter: the consultants' contract. , 1975, Lancet.

[28]  R. Soloway,et al.  Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy , 1971, The American Journal of Digestive Diseases.

[29]  J. Cadranel.  [Good clinical practice guidelines for fine needle aspiration biopsy of the liver: past, present and future]. , 2002, Gastroenterologie clinique et biologique.

[30]  F. Schaffner,et al.  Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.